More than 170 clinical trials using different IL-15 agents for cancer treatment have been initiated worldwide, but no IL-15 agonist drug/therapy has been approved for marketing so far (Waldmann et al., 2020a; Waldmann et al., 2020b). This evidence concerns the gene IL15 and cancer.